Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer

NCT04669197 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Untreated Resectable Pancreatic Adenocarcinoma
Borderline Resectable Pancreatic Adenocarcinoma
Locally Advanced Pancreatic Adenocarcinoma

Interventions

DRUG: Paclitaxel protein bound
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Hydroxychloroquine

Sponsor

HonorHealth Research Institute